Literature DB >> 24945185

High prevalence of esophageal dysmotility in asymptomatic obese patients.

Justin Côté-Daigneault, Pierre Leclerc, Josette Joubert, Mickael Bouin.   

Abstract

BACKGROUND: Obesity is an important health problem affecting >500 million people worldwide. Esophageal dysmotility is a gastrointestinal pathology associated with obesity; however, its prevalence and characteristics remain unclear. Esophageal dysmotilities have a high prevalence among obese patients regardless of gastrointestinal symptoms.
OBJECTIVE: To identify the prevalence of esophageal dysmotility among obese patients. The secondary goals were to characterize these pathologies in obese patients and identify risk factors.
METHOD: A prospective study from January 2009 to March 2010 at the University of Montreal Hospital Centre (Montreal, Quebec) was performed. Every patient scheduled for bariatric surgery underwent preoperatory esophageal manometry and was included in the study. Manometry was performed according to a standardized protocol with the following measures: superior esophageal sphincter - coordination and release during deglutition; esophageal body - presence, propagation, length, amplitude and type of esophageal waves of contraction; lower esophageal sphincter - localization, tone, release, intragastic pressure and intraesophageal pressure. All reference values were those used in the digestive motility laboratory. A gastrointestinal symptoms questionnaire was completed on the day manometry was performed. Chart reviews were performed to identify comorbidities and treatments that could influence the results.
RESULTS: A total of 53 patients were included (mean [± SD] age 43 ± 10 years; mean body mass index 46 ± 7 kg/m; 70% female). Esophageal manometry revealed dysmotility in 51% (n=27) of the patients. This dysmotility involved the esophageal body in 74% (n=20) of the patients and the inferior sphincter in 11% (n=3). Mixed dysmotility (body and inferior sphincter) was found in 15% (n=4) of cases. The esophageal body dysmotilities were hypomotility in 85% (n=23) of the patients, either from insignificant waves (74% [n=20]), nonpropagated waves (11% [n=3]) or low-amplitude waves (33% [n=9]). Gastroesophageal symptoms were found in 66% (n=35) of obese patients, including heartburn (66% [n=23]), regurgitation (26% [n=9]), dysphagia (43% [n=15]), chest pain (6% [n=2]) and dyspepsia (26% [n=9]). Among symptomatic patients, 51% (n=18) had normal manometry and 49% (n=17) had abnormal manometry (statistically nonsignificant). Among asymptomatic patients (n=18), 44% (n=8) had normal manometry and 56% (n=10) had abnormal manometry (statistically nonsignificant). Furthermore, no statistical differences were found between the normal manometry group and the abnormal manometry group with regard to medication intake or comorbidities.
CONCLUSION: Esophageal dysmotilities had a high prevalence in obese patients. Gastrointestinal symptoms cannot predict the presence of esophageal dysmotility. Hypomotility of the esophageal body is the most common dysmotility, especially from the absence of significant waves.

Entities:  

Mesh:

Year:  2014        PMID: 24945185      PMCID: PMC4072232          DOI: 10.1155/2014/960520

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  26 in total

Review 1.  AGA technical review on the clinical use of esophageal manometry.

Authors:  John E Pandolfino; Peter J Kahrilas
Journal:  Gastroenterology       Date:  2005-01       Impact factor: 22.682

2.  Diurnal and ultradian rhythmicity of plasma leptin: effects of gender and adiposity.

Authors:  M F Saad; M G Riad-Gabriel; A Khan; A Sharma; R Michael; S D Jinagouda; R Boyadjian; G M Steil
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Revision of failed gastric restrictive operations to Roux-en-Y gastric bypass: impact of multiple prior bariatric operations on outcome.

Authors:  Josh E Roller; David A Provost
Journal:  Obes Surg       Date:  2006-07       Impact factor: 4.129

4.  Peptide YY levels are elevated after gastric bypass surgery.

Authors:  Jean L Chan; Edward C Mun; Violeta Stoyneva; Christos S Mantzoros; Allison B Goldfine
Journal:  Obesity (Silver Spring)       Date:  2006-02       Impact factor: 5.002

Review 5.  The obesity pandemic: where have we been and where are we going?

Authors:  Jesse Roth; Xiaoling Qiang; Sharon Lee Marbán; Henry Redelt; Barbara C Lowell
Journal:  Obes Res       Date:  2004-11

Review 6.  Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus.

Authors:  Jingbo Zhao; Jens Brøndum Frøkjaer; Asbjørn Mohr Drewes; Niels Ejskjaer
Journal:  World J Gastroenterol       Date:  2006-05-14       Impact factor: 5.742

7.  High prevalence of asymptomatic esophageal motility disorders among morbidly obese patients.

Authors:  B W Jaffin; P Knoepflmacher; R Greenstein
Journal:  Obes Surg       Date:  1999-08       Impact factor: 4.129

8.  Radioimmunoassay of leptin in human plasma.

Authors:  Z Ma; R L Gingerich; J V Santiago; S Klein; C H Smith; M Landt
Journal:  Clin Chem       Date:  1996-06       Impact factor: 8.327

9.  Dysfunction of the lower esophageal sphincter and dysmotility of the tubular esophagus in morbidly obese patients.

Authors:  M A Küper; K M Kramer; A Kirschniak; A Kischniak; M Zdichavsky; J H Schneider; D Stüker; T Kratt; A Königsrainer; F A Granderath
Journal:  Obes Surg       Date:  2009-06-10       Impact factor: 4.129

10.  Impaired esophageal function in morbidly obese patients with gastroesophageal reflux disease: evaluation with multichannel intraluminal impedance.

Authors:  E Quiroga; F Cuenca-Abente; D Flum; E P Dellinger; B K Oelschlager
Journal:  Surg Endosc       Date:  2006-03-16       Impact factor: 4.584

View more
  14 in total

Review 1.  Gastrointestinal Complications of Obesity.

Authors:  Michael Camilleri; Harmeet Malhi; Andres Acosta
Journal:  Gastroenterology       Date:  2017-02-10       Impact factor: 22.682

2.  Per Oral Endoscopic Myotomy for the Management of Achalasia in a Patient with Prior Lap Band, Sleeve Gastrectomy, and Roux-en-Y Gastric Bypass.

Authors:  Gianfranco Donatelli; Fabrizio Cereatti; Antoine Soprani
Journal:  Obes Surg       Date:  2021-04-15       Impact factor: 4.129

Review 3.  Expanding Role of Third Space Endoscopy in the Management of Esophageal Diseases.

Authors:  Dennis Yang; Peter V Draganov
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03

4.  Transdiaphragmatic Pressure Gradient (TPG) Has a Central Role in the Pathophysiology of Gastroesophageal Reflux Disease (GERD) in the Obese and it Correlates with Abdominal Circumference but Not with Body Mass Index (BMI).

Authors:  Leonardo de Mello Del Grande; Fernando Augusto Mardiros Herbella; Rafael Caue Katayama; William Guidini Lima; Marco G Patti
Journal:  Obes Surg       Date:  2020-04       Impact factor: 4.129

5.  Outcomes of routine upper gastrointestinal series screening and surveillance after laparoscopic adjustable gastric banding.

Authors:  Danielle T Friedman; Andrew J Duffy
Journal:  Surg Endosc       Date:  2019-07-25       Impact factor: 4.584

Review 6.  Lesions in the oral cavity and esophagus caused by prescribed drugs: A review.

Authors:  Snezana Tesic-Rajkovic; Biljana Radovanovic-Dinic
Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub       Date:  2021-11-05       Impact factor: 1.245

7.  Usefulness of Upper Gastrointestinal Symptoms as a Driver to Prescribe Gastroscopy in Obese Patients Candidate to Bariatric Surgery. A Prospective Study.

Authors:  Marilia Carabotti; Marcello Avallone; Fabrizio Cereatti; Alessandro Paganini; Francesco Greco; Annunziata Scirocco; Carola Severi; Gianfranco Silecchia
Journal:  Obes Surg       Date:  2016-05       Impact factor: 4.129

8.  Upper Gastrointestinal Function in Morbidly Obese Adolescents Before and 6 Months After Gastric Banding.

Authors:  M Singendonk; S Kritas; T Omari; C Feinle-Bisset; A J Page; C L Frisby; S J Kentish; L Ferris; L McCall; L Kow; J Chisholm; S Khurana
Journal:  Obes Surg       Date:  2018-05       Impact factor: 4.129

9.  Plasma leptin concentrations and esophageal hypomotility in obese patients.

Authors:  Justin Côté-Daigneault; Pierre Poitras; Remi Rabasa-Lhoret; Mickael Bouin
Journal:  Can J Gastroenterol Hepatol       Date:  2015 Jan-Feb

10.  In vivo calibration of esophageal pressure in the mechanically ventilated patient makes measurements reliable.

Authors:  Francesco Mojoli; Giorgio Antonio Iotti; Francesca Torriglia; Marco Pozzi; Carlo Alberto Volta; Stefania Bianzina; Antonio Braschi; Laurent Brochard
Journal:  Crit Care       Date:  2016-04-11       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.